Hydroxyurea是一种通过抑制核糖核苷酸还原酶来阻断DNA合成的凋亡诱导剂,并具有抗正痘病毒活性。

-25~-15℃保存，有效期3年

[1] Lori F, Lisziewicz J. Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug. Clin Infect Dis. 2000 Jun,30 Suppl 2:S193-7. doi: 10.1086/313851. PMID: 10860905.[2]Watanapokasin Y, Chuncharunee S, Sanmund D, Kongnium W, Winichagoon P, Rodgers GP, Fucharoen S. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients. Exp Hematol. 2005 Dec,33(12):1486-92. doi: 10.1016/j.exphem.2005.09.006. PMID: 16338491.[3]Lebensburger JD, Pestina TI, Ware RE, Boyd KL, Persons DA. Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model. Haematologica. 2010 Sep,95(9):1599-603. doi: 10.3324/haematol.2010.023325. Epub 2010 Apr 7. PMID: 20378564, PMCID: PMC2930964.